Table 3.
Adverse events
Adverse event | Carrageenan (n = 141) |
Placebo (n = 139) |
pa |
---|---|---|---|
Any | 62 (44.0%) | 43 (30.9%) | 0.02 |
Unusually painful or heavy period | 0 | 3 (2.2%) | 0.08 |
Vaginal bleeding in between menstrual periods | 3 (2.1%) | 4 (2.9%) | 0.69 |
Pain during vaginal sex | 8 (5.7%) | 2 (1.4%) | 0.06 |
Unusual vaginal discharge | 8 (5.7%) | 2 (1.4%) | 0.06 |
Itching, burning or pain in genital area | 16 (11.3%) | 11 (7.9%) | 0.33 |
Genital sore/ulcer | 1 (0.7%) | 2 (1.4%) | 0.55 |
Needing to urinate more often than usual | 1 (0.7%) | 3 (2.2%) | 0.31 |
Pain while urinating | 4 (2.8%) | 1 (0.7%) | 0.18 |
Blood in urine | 3 (2.1%) | 1 (0.7%) | 0.32 |
Lower abdominal pain | 2 (1.4%) | 0 | 0.16 |
Lower back pain | 0 | 0 | — |
Other | 16 (11.3%) | 14 (10.1%) | 0.73 |
By z test.